SMTL ID : 7pyr.1

Crystal structure of the adenosine A2A receptor (A2A-PSB1-bRIL) in complex with preladenant conjugate PSB-2115

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

3 x CLR: CHOLESTEROL(Non-covalent)

CLR.1: 7 residues within 4Å: Chain A: L.212, L.368, I.372, C.375, F.376, F.379, C.380 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.212, A:L.368, A:I.372, A:F.376, A:F.376, A:F.376, A:F.379 Water bridges: A:F.379 CLR.2: 11 residues within 4Å: Chain A: L.365, L.368, P.369, I.372, I.373, F.376, C.383, S.384, A.386, L.390 Ligands: OLA.26 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.365, A:L.368, A:P.369, A:I.372, A:I.373, A:F.376, A:A.386, A:L.390 Hydrogen bonds: A:S.384 CLR.3: 8 residues within 4Å: Chain A: A.97, A.98, G.101, F.104, I.105 Ligands: OLA.18, OLA.19, OLC.33 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.97, A:F.104, A:I.105, A:I.105 Hydrogen bonds: A:A.98

1 x 8IM: 2-[2-[2-[2-[2-[2-[4-[4-[2-[7-azanyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl]piperazin-1-yl]phenoxy]ethanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]-~{N}-[5-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-1,3-diaza-2$l^{4}-boratricyclo[7.3.0.0^{3,7}]dodeca-4,6,9,11-tetraen-8-yl]pentyl]ethanamide(Non-covalent)

8IM.4: 16 residues within 4Å: Chain A: S.92, T.93, L.110, F.193, E.194, M.202, W.367, L.370, H.371, N.374, H.385, A.386, L.388, M.391, Y.392, I.395 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.110, A:F.193, A:W.367, A:L.370, A:H.385, A:I.395 Hydrogen bonds: A:N.374, A:N.374, A:N.374 Water bridges: A:K.178 Salt bridges: A:E.194 pi-Stacking: A:F.193, A:F.193, A:H.385

25 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)

OLA.5: 4 residues within 4Å: Chain A: F.118, A.122, I.125 Ligands: OLA.15 Ligand excluded by PLIP OLA.6: 6 residues within 4Å: Chain A: I.28, S.31, S.32, I.35, T.36 Ligands: OLA.21 Ligand excluded by PLIP OLA.7: 10 residues within 4Å: Chain A: V.82, P.86, I.89, T.90, T.93, F.95 Ligands: OLA.8, OLA.9, OLA.21, OLC.33 Ligand excluded by PLIP OLA.8: 3 residues within 4Å: Ligands: OLA.7, OLA.9, OLC.33 Ligand excluded by PLIP OLA.9: 3 residues within 4Å: Ligands: OLA.7, OLA.8, OLA.21 Ligand excluded by PLIP OLA.10: 3 residues within 4Å: Chain A: F.226, V.350, K.354 Ligand excluded by PLIP OLA.11: 6 residues within 4Å: Chain A: G.30, S.31, Y.34, L.388, Y.392, V.396 Ligand excluded by PLIP OLA.12: 4 residues within 4Å: Chain A: I.28, M.29, S.32, V.33 Ligand excluded by PLIP OLA.13: 1 residues within 4Å: Ligands: OLA.29 Ligand excluded by PLIP OLA.14: 3 residues within 4Å: Chain A: I.358, G.361 Ligands: OLA.23 Ligand excluded by PLIP OLA.15: 5 residues within 4Å: Chain A: L.121, I.125, L.217, V.221 Ligands: OLA.5 Ligand excluded by PLIP OLA.16: 1 residues within 4Å: Chain A: W.389 Ligand excluded by PLIP OLA.17: 4 residues within 4Å: Chain A: C.53, I.78, V.82 Ligands: OLA.25 Ligand excluded by PLIP OLA.18: 2 residues within 4Å: Ligands: CLR.3, OLA.19 Ligand excluded by PLIP OLA.19: 4 residues within 4Å: Chain A: M.165 Ligands: CLR.3, OLA.18, OLA.28 Ligand excluded by PLIP OLA.20: 4 residues within 4Å: Chain A: Y.204, F.208, L.212 Ligands: OLC.31 Ligand excluded by PLIP OLA.21: 5 residues within 4Å: Chain A: I.35, L.39 Ligands: OLA.6, OLA.7, OLA.9 Ligand excluded by PLIP OLA.22: 4 residues within 4Å: Chain A: L.44, V.404, F.407 Ligands: OLA.24 Ligand excluded by PLIP OLA.23: 3 residues within 4Å: Chain A: A.357, G.361 Ligands: OLA.14 Ligand excluded by PLIP OLA.24: 4 residues within 4Å: Chain A: T.400, F.407, I.408 Ligands: OLA.22 Ligand excluded by PLIP OLA.25: 6 residues within 4Å: Chain A: V.56, V.71, A.75, I.78 Ligands: OLA.17, OLC.32 Ligand excluded by PLIP OLA.26: 3 residues within 4Å: Chain A: W.389, L.390 Ligands: CLR.2 Ligand excluded by PLIP OLA.27: 8 residues within 4Å: Chain A: K.147, W.154, V.155, F.158, A.159, L.162 Ligands: OLA.28, OLC.32 Ligand excluded by PLIP OLA.28: 5 residues within 4Å: Chain A: F.158, L.162, M.165 Ligands: OLA.19, OLA.27 Ligand excluded by PLIP OLA.29: 6 residues within 4Å: Chain A: L.216, G.220, L.223, R.224, L.227 Ligands: OLA.13 Ligand excluded by PLIP

4 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.30: 5 residues within 4Å: Chain A: G.148, I.152, A.159, T.163 Ligands: PEG.35 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.152, A:I.152, A:A.159 OLC.31: 4 residues within 4Å: Chain A: Y.204, F.208, A.209 Ligands: OLA.20 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.204, A:F.208, A:A.209 OLC.32: 7 residues within 4Å: Chain A: Y.68, V.71, A.75, K.147, W.154 Ligands: OLA.25, OLA.27 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:A.75, A:W.154, A:W.154 OLC.33: 8 residues within 4Å: Chain A: L.83, F.87, T.90, F.95, C.96 Ligands: CLR.3, OLA.7, OLA.8 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.83, A:F.87, A:T.90, A:F.95 Water bridges: A:C.96

2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.34: 2 residues within 4Å: Chain A: R.145 Ligands: PEG.35 No protein-ligand interaction detected (PLIP) PEG.35: 6 residues within 4Å: Chain A: T.144, R.145, G.148, I.149 Ligands: OLC.30, PEG.34 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Claff, T. et al., Single Stabilizing Point Mutation Enables High-Resolution Co-Crystal Structures of the Adenosine A 2A Receptor with Preladenant Conjugates. Angew.Chem.Int.Ed.Engl. (2022)

Release Date

2022-03-02

Peptides

Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a

Related Entries With Identical Sequence